ArticleFrontiers in physiology2017

Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib.

Svantje Sobotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.